Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
---|---|---|---|---|---|---|---|---|---|---|---|
CXSB2300123 | 注射用QLS31904 | QLS-31904 | Lyophilized | Biological Products(1) | Supplementary Application | 2023-11-04 | QILU Pharmaceutical Co Ltd | view | |||
CXSL2200113 | 注射用QLS31904 | QLS-31904 | Lyophilized | Biological Products(1) | New Drug Application | 2022-03-04 | QILU Pharmaceutical Co Ltd | view |